9.30 Panel Discussion | Assessing the Invasiveness of Local Administration Over Systemic Injection: Do the Risks Outweigh the Rewards?
Time: 9:30 am
day: Day One
Details:
- Making the case that a given CNS disorder requires local delivery: Is there sufficient evidence to support the requirement for a direct RoA?
- How does level of invasiveness differ depending on drug modality? Are genetic medicines safer to consider for local delivery due to one-time dosing?
- Which brain regions hold the most promise for targeting through device-mediated approaches?
